Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

The reason for this finding of no disease-free survival difference in most patients "is unclear," wrote Toon Van Gorp, MD, with Leuven Cancer Institute in Leuven, Belgium, and his fellow study authors ...

A team of researchers at the VIB-KU Leuven Center for Cancer Biology, the Netherlands Cancer Institute and Oncode Institute ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

The combination did not benefit a biomarker unselected population, but those with mismatch repair-deficient tumors had extended disease-free survival.

Study findings were mixed regarding the postsurgical combination of Keytruda and chemotherapy with or without radiation among ...

in Leuven, Belgium, said in an oral presentation during the meeting. Pembrolizumab plus chemotherapy is approved as a ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 16 on August 29, 2024, entitled, "Leukocyte telomere ...

Research in zebrafish and mouse models reveals targeting EGLN2 could potentially reduce inflammation and slow down the progression of ALS.

Oxidative stress, metabolic dysfunction, and neuroinflammation are well-known hallmarks of ALS, which gave the researchers a target for their quest to understand the disease: a group of enzymes called ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons. The average life ...